The Future of GLP-1 Pricing The popularity of GLP-1 medications has triggered significant pharmaceutical competition
PMID: 22 AppelmanBCharltonBTGouldingRPKerkhoffTJBreedveldEANoortWet al
In December 2025, the FDA also expanded the Mounjaro indication to include paediatric patients aged ten and over with type 2 diabetes, following results from the SURPASS-PEDS trial
Casos de diarreas, ya que pueden agravarse y crear casos graves de trastornos gastrointestinales Si padeces epilepsia, ya que ests sobreestimulando a tu sistema y si sufres un ataque, las convulsiones, son ms fuertes
What if youre not getting enough vegetables
This partnership was the first time an FDA-cleared weight management aid or primary care product was made available at launch nationwide via telehealth providing immediate access to patients regardless of insurance status, zip code, or provider availability in their area